首页> 美国政府科技报告 >Epigenetic Therapy of Hematopoietic Malignancies: Novel Approaches for Tissue-Specific and Global Inhibition of EZH2 Enzymatic Activities.

【24h】

Epigenetic Therapy of Hematopoietic Malignancies: Novel Approaches for Tissue-Specific and Global Inhibition of EZH2 Enzymatic Activities.

机译：造血系统恶性肿瘤的表观遗传治疗：组织特异性和全局抑制EZH2酶活性的新方法。

获取原文

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Wang, G.;
展开▼
作者单位

展开▼
年度 2016
页码 1-15
总页数 15
原文格式 PDF
正文语种 eng
中图分类
关键词
Therapeutics; Inhibitors; Hematopoietic system; Mutations; Methylation; Gene expression; Blood; Lymphocytes; Hematopoietic cancer; Prc2; Histone methylation;

机译：治疗学;抑制剂;造血系统;突变;甲基化;基因表达;血液;淋巴细胞;造血系统癌; prc2;组蛋白甲基化;

相似文献

外文文献
中文文献
专利

1. Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells [J] . Takashina Taichi, Kinoshita Ichiro, Kikuchi Junko, Cancer science. . 2016,第7期

机译：联合抑制EZH2和组蛋白脱乙酰基酶作为非小细胞肺癌细胞的潜在表观遗传学治疗方法
2. Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non‐small‐cell lung cancer cells [J] . Cancer science. . 2016,第7期

机译：EZH2和组蛋白脱乙酰酶的结合抑制作用非小细胞肺癌细胞的潜在表观遗传疗法
3. Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells [J] . Takashina Taichi, Kinoshita Ichiro, Kikuchi Junko, Cancer science. . 2016,第7期

机译：EZH2和组蛋白脱乙酰酶的结合抑制作用非小细胞肺癌细胞的潜在表观遗传疗法
4. Enzymatic hydrolase-, or oxidoreduc- tase- based approaches for yellowing inhibition of high yield pulps and pulp delignification [C] . Hans-Peter Call, Simon Call Appita Annual Conference and Exhibition incorporating the ISWFPC(International Symposium on Wood, Fibre and Pulping Chemistry) vol.2: 13th ISWFPC Sessions - Oral Papers; 20050516-19; Auckland(NZ) . 2005

机译：基于酶水解酶或氧化还原酶的方法可抑制高产纸浆的泛黄和纸浆脱木素
5. The burden of parainfluenza virus infection in patients with hematological malignancy and hematopoietic stem cell transplant (HSCT) recipients in the absence of active immunization and approved therapy: The role of infection control. [D] . Hanmod, Santosh S. 2009

机译：在没有积极免疫和批准治疗的情况下，血液恶性肿瘤和造血干细胞移植（HSCT）患者的副流感病毒感染负担：感染控制的作用。
6. Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non‐small‐cell lung cancer cells [O] . Taichi Takashina, Ichiro Kinoshita, Junko Kikuchi, 2016

机译：联合抑制EZH2和组蛋白脱乙酰基酶可作为非小细胞肺癌细胞的潜在表观遗传学治疗方法
7. Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells [O] . Takashina, Taichi, Kinoshita, Ichiro, Kikuchi, Junko, 2016

机译：联合抑制EZH2和组蛋白脱乙酰基酶作为非小细胞肺癌细胞的潜在表观遗传学治疗方法
8. Epigenetic Therapy of Hematopoietic Malignancies: Novel Approaches for Tissue-Specific and Global Inhibition of EZH2 Enzymatic Activities. [R] . Wang, G. 2017

机译：造血系统恶性肿瘤的表观遗传治疗：组织特异性和全局抑制EZH2酶活性的新方法。

Epigenetic Therapy of Hematopoietic Malignancies: Novel Approaches for Tissue-Specific and Global Inhibition of EZH2 Enzymatic Activities.

著录项

引文网络

相似文献

相关主题

期刊订阅